Development of the B cell cancer vaccine HER-vaxx for the treatment of her-2 expressing cancers

Her-2/neu is a tumor-associated protein that is overexpressed in a number of malignancies, including advanced cancer of the stomach, and has been proposed as a human cancer vaccine target. Overexpression of Her-2/neu in human breast and gastric carcinomas correlates with a more aggressive course of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ede, Nicholas J., Good, Anthony J., Tobias, Joshua, Garner-Spitzer, Erika, Zielinski, Christoph C., Wiedermann, Ursula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791928/
https://www.ncbi.nlm.nih.gov/pubmed/36578947
http://dx.doi.org/10.3389/fonc.2022.939356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791928/
https://www.ncbi.nlm.nih.gov/pubmed/36578947
http://dx.doi.org/10.3389/fonc.2022.939356

Ejemplares similares